Reliable clinical communication
How results are explained and what happens next matter as much as the result itself.
With Omega Genetics expertise, we offer a clear, reassuring and guided SMA carrier-assessment pathway for preconception and prenatal planning.
Carrier frequency
1 / 50
SMA carrier status is seen at a notable frequency in Türkiye.
Prenatal assessment
10+
Further assessment options can be planned early in pregnancy for carrier couples.
When both partners are carriers
25%
Affected child
50%
Carrier child
25%
Non-carrier child
These probabilities should be interpreted within genetic counselling.
How results are explained and what happens next matter as much as the result itself.
Genetic analysis is planned with the clinical context in mind.
Timing before and during pregnancy directly affects available decisions.
Preconception screening is therefore both a test and a decision-support process.
Approximately one in 50 people is an SMA carrier, so risk becomes visible through systematic screening.
If both parents are carriers, each pregnancy has a 25% affected-child and 50% carrier-child probability.
Assessment before or during pregnancy helps families manage subsequent decisions consciously.
SMA assessment is especially relevant for couples planning pregnancy, people with a family history and those with a known carrier result.
Knowing carrier status before conception enables more controlled risk assessment.
A family history of SMA or unexplained infant loss makes genetic screening more important.
Carrier screening can provide informed decision support before marriage.
If one partner is a carrier, the other should be assessed and prenatal planning considered if needed.
SMA assessment serves different purposes before pregnancy and during the prenatal period for carrier couples.
This is the ideal time. A simple blood sample supports risk assessment and planning before pregnancy.
For carrier couples, chorionic villus sampling or amniocentesis may be considered with a physician.
Every step, from first contact to result guidance, is planned to support clinical decisions.
We call you, review family history and clarify the most suitable pathway.
Our Ankara-based laboratory infrastructure supports sample acceptance and guidance throughout Türkiye.
The sample is examined with appropriate molecular methods and interpreted for carrier or prenatal risk.
Findings are explained clearly and further counselling is planned where needed.
SMA testing involves carrier status, prenatal options and subsequent clinical decisions. We treat content, communication and guidance with equal care.
Genetic testing requires accurate interpretation and guidance as well as technical analysis.
Sample and communication processes are coordinated across Türkiye, not only Ankara.
We provide a clear framework for prenatal diagnostic options when risk is identified.
We translate complex genetic terminology into everyday language.

⌂ Ankara central laboratory
Our central laboratory, where molecular genetic analyses are performed, is located on Piri Reis Caddesi in Beytepe, Ankara. Sample acceptance and communication are coordinated from anywhere in Türkiye, with courier and routing organised by our team.
Ankara
Central laboratory location
TR
Nationwide sample network
3
Supported languages
Home sample collection
Home sample collection is organised by Omega Çare, our specialist home healthcare team.
Your question may not be listed. Contact our team for information relevant to you.
Quick contact
Let us call you about sample coordination, timing, carrier-couple risk and prenatal assessment.
Our team will contact you about testing time, sample flow and the assessment steps suitable for you.
☎ +90 507 743 86 88